Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
A T Jotheeswaran; Nukala Lovakanth; Shruthi Nadiga; Raghupathy Anchala; G. V. S. Murthy; Clare E Gilbert (2016)
Publisher: Wolters Kluwer Medknow Publications
Journal: Indian Journal of Endocrinology and Metabolism
Languages: English
Types: Article
Subjects: Diseases of the digestive system. Gastroenterology, Original Article, screening, RC648-665, RC799-869, meta-analysis, Diseases of the endocrine glands. Clinical endocrinology, diabetic retinopathy, India, Diabetes
Background: Available evidence from India shows that the control of diabetes is poor in majority of the population. This escalates the risk of complications. There is no systematic review to estimate the magnitude of diabetic retinopathy (DR) in India. Materials and Methods: A systematic literature search was carried out in Ovid Medline and EMBASE databases using Mesh and key search terms. Studies which reported the proportion of people with diabetes with DR in a representative community population were included. Two independent reviewers reviewed all the retrieved publications. Data were extracted using a predefined form. Review Manager software was used to perform meta-analysis to provide a pooled estimate. Studies included were assessed for methodological quality using selected items from the STROBE checklist. Results: Seven studies (1999–2014; n = 8315 persons with diabetes) were included in the review. In the meta-analysis, 14.9% (95% confidence interval [CI] 10.7–19.0%) of known diabetics aged ≥30 years and 18.1% (95% CI 14.8–21.4) among those aged ≥50 years had DR. Heterogeneity around this estimate ranged from I2= 79–87%. No linear trend was observed between age and the proportion with DR. The overall methodological quality of included studies was moderate. Conclusions: Early detection of DR is currently not prioritized in public health policies for noncommunicable diseases and blindness programs. Methodological issues in studies suggest that the proportion of diabetics with DR is underestimated in the Indian population. Future research should emphasize more robust methodology for assessing diabetes and DR status.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Scanlon PH, Aldington SJ, Stratton IM. Epidemiological issues in diabetic retinopathy. Middle East Afr J Ophthalmol 2013;20:293-300.
    • 2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-53.
    • 3. Jayawardena R, Ranasinghe P, Byrne NM, Soares MJ, Katulanda P, Hills AP. Prevalence and trends of the diabetes epidemic in South Asia: A systematic review and meta-analysis. BMC Public Health 2012;12:380.
    • 4. Joshi SR, Saboo B, Vadivale M, Dani SI, Mithal A, Kaul U, et al. Prevalence of diagnosed and undiagnosed diabetes and hypertension in India - Results from the screening India's twin epidemic (SITE) study. Diabetes Technol Ther 2012;14:8-15.
    • 5. Venkataraman K, Kannan AT, Mohan V. Challenges in diabetes management with particular reference to India. Int J Diabetes Dev Ctries 2009;29:103-9.
    • 6. Roodhooft JM. Leading causes of blindness worldwide. Bull Soc Belge Ophtalmol 2002;283:19-25.
    • 7. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care 2012;35:556-64.
    • 8. Rema M, Pradeepa R. Diabetic retinopathy: An Indian perspective. Indian J Med Res 2007;125:297-310.
    • 9. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: A worldwide perspective. Surv Ophthalmol 2012;57:347-70.
    • 10. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int J Surg 2010;8:336-41.
    • 11. Sunita M, Desai S, Vinay P, Moolani S, Rai N, Deepen S, et al. Aditya Jyot-diabetic retinopathy in Urban Mumbai Slums study (AJ-DRUMSS): Study design and methodology - Report 1. Ophthalmic Epidemiol 2014;21:51-60.
    • 12. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
    • 13. Campbell MJ. Statistics at Square One. 9th ed. London: BMJ Publishing Group; 1997.
    • 14. Cox AR. Improving on the Range - Rule of thumb. Rose Hulman Undergrad Math J 2012;13:1-13.
    • 15. Dandona L, Dandona R, Naduvilath TJ, McCarty CA, Rao GN. Population based assessment of diabetic retinopathy in an urban population in Southern India. Br J Ophthalmol 1999;83:937-40.
    • 16. Jonas JB, Nangia V, Khare A, Matin A, Bhojwani K, Kulkarni M, et al. Prevalence and associated factors of diabetic retinopathy in rural central India. Diabetes Care 2013;36:e69.
    • 17. Namperumalsamy P, Kim R, Vignesh TP, Nithya N, Royes J, Gijo T, et al. Prevalence and risk factors for diabetic retinopathy: A population-based assessment from Theni district, South India. Br J Ophthalmol 2009;93:429-34.
    • 18. Narendran V, John RK, Raghuram A, Ravindran RD, Nirmalan PK, Thulasiraj RD. Diabetic retinopathy among self reported diabetics in Southern India: A population based assessment. Br J Ophthalmol 2002;86:1014-8.
    • 19. Raman R, Rani PK, Reddi Rachepalle S, Gnanamoorthy P, Uthra S, Kumaramanickavel G, et al. Prevalence of diabetic retinopathy in India: Sankara nethralaya diabetic retinopathy epidemiology and molecular genetics study report 2. Ophthalmology 2009;116:311-8.
    • 20. Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban rural epidemiology study (CURES) eye study, I. Invest Ophthalmol Vis Sci 2005;46:2328-33.
    • 21. Song SJ, Wong TY. Current concepts in diabetic retinopathy. Diabetes Metab J 2014;38:416-25.
    • 22. Sivaprasad S, Gupta B, Gulliford MC, Dodhia H, Mohamed M, Nagi D, et al. Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK). PLoS One 2012;7:e32182.
    • 23. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 2010;304:649-56.
    • 24. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: A systematic review. J Hypertens 2004;22:11-9.
    • 25. Beagley J, Guariguata L, Weil C, Motala AA. Global estimates of undiagnosed diabetes in adults. Diabetes Res Clin Pract 2014;103:150-60.
    • 26. McNamee R. Efficiency of two-phase designs for prevalence estimation. Int J Epidemiol 2003;32:1072-8.
    • 27. Prince M. Commentary: Two-phase surveys. A death is announced; no flowers please. Int J Epidemiol 2003;32:1078-80.
    • 28. Altman DG, Bland JM. Diagnostic tests 1: Sensitivity and specificity. BMJ 1994;308:1552.
    • 29. Loong TW. Understanding sensitivity and specificity with the right side of the brain. BMJ 2003;327:716-9.
    • 30. Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 2007;125:217-30.
    • 31. Garg S, Davis RM. Diabetic retinopathy screening update. Clin Diabetes 2009;27:140-5.
    • 32. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of Type 2 diabetes: A systematic review. Diabet Med 2007;24:333-43.
    • 33. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care 2003;26 suppl 1:s21-4.
    • 34. Somannavar S, Ganesan A, Deepa M, Datta M, Mohan V. Random capillary blood glucose cut points for diabetes and pre-diabetes derived from community-based opportunistic screening in India. Diabetes Care 2009;32:641-3.
    • 35. Sharma T. How necessary is the second estimation of fasting plasma glucose level by laboratory venous blood to diagnose Type 2 diabetes, particularly in epidemiological studies? Ophthalmic Epidemiol 2006;13:281-2.
    • 36. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2197-223.
    • 37. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2163-96.
    • 38. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137-49.
    • 1: s eaRch etRMs
  • Inferred research data

    The results below are discovered through our pilot algorithms. Let us know how we are doing!

    Title Trust
  • No similar publications.